- Home
- HSCS vs MTNB Comparison
HSCS vs MTNB Comparison
Compare HSCS & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- MTNB
- Stock Information
- Founded
- HSCS 2007
- MTNB 2013
- Country
- HSCS United States
- MTNB United States
- Employees
- HSCS N/A
- MTNB N/A
- Industry
- HSCS Medical Specialities
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- MTNB Health Care
- Exchange
- HSCS Nasdaq
- MTNB Nasdaq
- Market Cap
- HSCS 2.8M
- MTNB 3.1M
- IPO Year
- HSCS 2022
- MTNB N/A
- Fundamental
- Price
- HSCS $3.17
- MTNB $0.54
- Analyst Decision
- HSCS Strong Buy
- MTNB Hold
- Analyst Count
- HSCS 2
- MTNB 1
- Target Price
- HSCS $13.50
- MTNB N/A
- AVG Volume (30 Days)
- HSCS 16.4K
- MTNB 288.0K
- Earning Date
- HSCS 03-25-2025
- MTNB 05-08-2025
- Dividend Yield
- HSCS N/A
- MTNB N/A
- EPS Growth
- HSCS N/A
- MTNB N/A
- EPS
- HSCS N/A
- MTNB N/A
- Revenue
- HSCS $14,700.00
- MTNB N/A
- Revenue This Year
- HSCS $174.19
- MTNB N/A
- Revenue Next Year
- HSCS $4,100.00
- MTNB N/A
- P/E Ratio
- HSCS N/A
- MTNB N/A
- Revenue Growth
- HSCS 151.28
- MTNB N/A
- 52 Week Low
- HSCS $2.36
- MTNB $0.48
- 52 Week High
- HSCS $13.50
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- HSCS 35.81
- MTNB 40.98
- Support Level
- HSCS $2.62
- MTNB $0.52
- Resistance Level
- HSCS $3.09
- MTNB $0.57
- Average True Range (ATR)
- HSCS 0.32
- MTNB 0.05
- MACD
- HSCS -0.09
- MTNB -0.00
- Stochastic Oscillator
- HSCS 20.55
- MTNB 9.95
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.